Every SEC Form 3/4/5 on record for this filer (CIK 1722234) — 4 issuers, 7 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | Director | 2023-11-02 → 2026-06-29 | 5 | — |
| SCPH | scPharmaceuticals Inc. | Director | 2017-11-16 → 2025-10-07 | 10 | $9M |
| IMRA | IMARA Inc. | Director · lapsed | 2020-03-11 → 2020-03-16 | 2 | $3M |
| TRVI | Trevi Therapeutics, Inc. | Director · lapsed | 2019-05-07 → 2019-05-13 | 3 | $4M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| IMRA | 2020-03-16 | Buy | 187,500 | $16.00 | $3M | 1,432,722 |
| TRVI | 2019-05-09 | Buy | 375,000 | $10.00 | $4M | 1,151,544 |
| SCPH | 2017-11-21 | Buy | 654,762 | $14.00 | $9M | 3,183,986 |
2 of 4 issuers are covered and open a security page; the rest are on file here only.